UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2576
Structure Therapeutics
GPCR
$1.82B
| $86.5K | ﹤0.01% |
4,170
-1,745
| -30% | -$38.4K |
2025 Q1
1 quarter
|
|
2577
Hello Group
MOMO
$678M
| $86.2K | ﹤0.01% |
10,212
-19,291
| -65% | -$126K |
2024 Q2
4 quarters
|
|
2578
Absci
ABSI
$1.74B
| $84.2K | ﹤0.01% |
32,750
+1,575
| +5% | +$4.43K |
2025 Q1
1 quarter
|
|
2579
Vanda Pharmaceuticals
VNDA
$276M
| $82.9K | ﹤0.01% |
+17,565
| New | +$76.8K |
2025 Q2
0 quarters
|
|
2580
Playtika
PLTK
$873M
| $73.3K | ﹤0.01% |
15,501
| – | – |
2025 Q1
1 quarter
|
|
2581
Acco Brands
ACCO
$414M
| $70.4K | ﹤0.01% |
19,664
-321,945
| -94% | -$1.19M |
2013 Q2
48 quarters
|
|
2582
Silicon Motion
SIMO
$8.95B
| $67.7K | ﹤0.01% |
900
-100
| -10% | -$5.68K |
2025 Q1
1 quarter
|
|
2583
WisdomTree Global High Dividend Fund
DEW
$157M
| $63K | ﹤0.01% |
+1,103
| New | +$61.2K |
2025 Q2
0 quarters
|
|
2584
DELISTED
Berry Corp
BRY
| $53.5K | ﹤0.01% |
+19,332
| New | +$51.7K |
2025 Q2
0 quarters
|
|
2585
CMB.TECH NV
CMBT
$5.98B
| $52.2K | ﹤0.01% |
5,788
+5,653
| +4,187% | +$51.6K |
2025 Q1
1 quarter
|
|
2586
MINISO
MNSO
$2.81B
| $51.7K | ﹤0.01% |
+2,836
| New | +$50.9K |
2025 Q2
0 quarters
|
|
2587
Inogen
INGN
$164M
| $45.5K | ﹤0.01% |
+6,477
| New | +$43.6K |
2025 Q2
0 quarters
|
|
2588
Dauch Corp
DCH
$1.35B
| $40.8K | ﹤0.01% |
10,010
-350,753
| -97% | -$1.41M |
2023 Q4
6 quarters
|
|
2589
DELISTED
Anywhere Real Estate
HOUS
| $40.5K | ﹤0.01% |
+11,178
| New | +$39K |
2025 Q2
0 quarters
|
|
2590
Huya Inc
HUYA
$516M
| $26.7K | ﹤0.01% |
7,588
-27,300
| -78% | -$99K |
2024 Q2
4 quarters
|
|
2591
Wolfspeed
WOLF
$1.62B
| $25.9K | ﹤0.01% |
64,822
-1,803,919
| -97% | -$4.11M |
2021 Q4
14 quarters
|
|
2592
Amplify Mobile Payments ETF
IPAY
$153M
| $20.9K | ﹤0.01% |
+348
| New | +$19.1K |
2025 Q2
0 quarters
|
|
2593
Franklin US Low Volatility High Dividend Index ETF
LVHD
$598M
| $19.9K | ﹤0.01% |
+500
| New | +$19.8K |
2025 Q2
0 quarters
|
|
2594
Hain Celestial
HAIN
$50.4M
| $18.9K | ﹤0.01% |
12,425
| – | – |
2013 Q2
48 quarters
|
|
2595
Altimmune
ALT
$508M
| $16.3K | ﹤0.01% |
4,215
-102,657
| -96% | -$556K |
2024 Q1
5 quarters
|
|
2596
D-Market Electronic Services & Trading
HEPS
$1.17B
| $16.2K | ﹤0.01% |
6,000
+1,800
| +43% | +$4.89K |
2025 Q1
1 quarter
|
|
2597
Ironwood Pharmaceuticals
IRWD
$631M
| $15.5K | ﹤0.01% |
21,643
-265,347
| -92% | -$208K |
2013 Q2
48 quarters
|
|
2598
Lotus Technology
LOT
$444M
| $14.1K | ﹤0.01% |
+6,400
| New | +$12K |
2025 Q2
0 quarters
|
|
2599
New Mountain Finance
NMFC
$636M
| $13.8K | ﹤0.01% |
1,306
-44,194
| -97% | -$456K |
2025 Q1
1 quarter
|
|
2600
Choiceone Financial
COFS
$486M
| $4.59K | ﹤0.01% |
+160
| New | +$4.54K |
2025 Q2
0 quarters
|
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.